WithdrawnNot Applicable

Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia

Stopped: As of 12/18/2017 notification of early closure of the trial due to lack of recruitment.

Spain0Started 2013-09-16

Plain-language summary

* Androgenetic alopecia (AGA) or common baldness is the most common cause of hair loss in both men and women and is caused by the action of androgens in genetically predisposed individuals. * This clinical trial was designed to evaluate the efficacy and safety of using a preparation of autologous plasma rich in growth factors (PRGF-Endoret) in the treatment of androgenetic alopecia.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Androgenetic alopecia according to the following scales: * Men: Hamilton/Norwood Scale: grades II-VI * Women: Ludwig Scale grades I-II. * Possibility of follow-up during the study Exclusion Criteria: * No androgenetic alopecia * Telogen and anagen effluvium * Active inflammation or infection in the intervention area * Presence of active systemic infections. * Background of cancerous or precancerous lesions. * Background of connective or rheumatic diseases. * Suffering from any serious blood disorders. * To have undergone treatments for alopecia in the previous 6 months. * Previous hair implants * Intake of drugs that affect hair loss. * Be undergoing immunosuppressive therapy and/or anticoagulants. * Known intolerance to mesotherapy. * Taking contraceptives containing cyproterone acetate. * Pregnancy * In general, any limitations that would prevent the proper application of both treatments and the right monitoring of the efficacy variables.

What they're measuring

Change from baseline in Hair density at three months (number of hairs per cm2)

Timeframe: 3 months post-treatment

Trial details

NCT IDNCT01885676

SponsorBiotechnology Institute IMASD

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2015-09